APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artemisinin and Derivatives

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Artemisinin and Derivatives Industry Growth and Trends Forecast to 2032

23 December 202594 pages

Choose your research edition.

Industry ResearchArtemisinin and Derivatives Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Artemisinin and Derivatives Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Artemisinin and Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artemisinin and Derivatives Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Artemisinin and Derivatives Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Artemisinin and Derivatives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Artemisinin and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Artemisinin and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artemisinin and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Artemisinin and Derivatives include Ipca Laboratories, Guilin Nantang Pharmaceutical, KPC Pharmaceuticals, Chongqing Kerui Nanhai Pharmaceutical, Sichuan Xieli Pharmaceutical, Cerata Pharmaceuticals and Aqre Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Artemisinin and Derivatives market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Artemisinin and Derivatives market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Artemisinin and Derivatives market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Artemisinin and Derivatives.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Artemisinin and Derivatives market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Artemisinin and Derivatives Market by Company

Ipca Laboratories

Guilin Nantang Pharmaceutical

KPC Pharmaceuticals

Chongqing Kerui Nanhai Pharmaceutical

Sichuan Xieli Pharmaceutical

Cerata Pharmaceuticals

Aqre Group

Artemisinin and Derivatives Segment by Type

Artemether

Artesunate

Artemisinin

Dihydroartemisinin

Artemisinin and Derivatives Segment by Application

Antitumor and Anti-inflammatory Drugs

Antimalarial Drugs

Artemisinin and Derivatives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemisinin and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artemisinin and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemisinin and Derivatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Artemisinin and Derivatives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Artemisinin and Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Artemether Table 2. Major Company of Artesunate Table 3. Major Company of Artemisinin Table 4. Major Company of Dihydroartemisinin Table 5. Global Artemisinin and Derivatives Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons) Table 7. Global Artemisinin and Derivatives Sales Market Share in Volume by Type (2021-2026) Table 8. Global Artemisinin and Derivatives Sales by Type (2021-2026) & (US$ Million) Table 9. Global Artemisinin and Derivatives Sales Market Share in Value by Type (2021-2026) Table 10. Global Artemisinin and Derivatives Price by Type (2021-2026) & (US$/Ton) Table 11. Global Artemisinin and Derivatives Sales by Type (2027-2032) & (Tons) Table 12. Global Artemisinin and Derivatives Sales Market Share in Volume by Type (2027-2032) Table 13. Global Artemisinin and Derivatives Sales by Type (2027-2032) & (US$ Million) Table 14. Global Artemisinin and Derivatives Sales Market Share in Value by Type (2027-2032) Table 15. Global Artemisinin and Derivatives Price by Type (2027-2032) & (US$/Ton) Table 16. North America Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons) Table 17. North America Artemisinin and Derivatives Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons) Table 19. Europe Artemisinin and Derivatives Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons) Table 21. Asia-Pacific Artemisinin and Derivatives Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons) Table 23. Latin America Artemisinin and Derivatives Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons) Table 25. Middle East and Africa Artemisinin and Derivatives Sales by Type (2021-2026) & (US$ Million) Table 26. Artemisinin and Derivatives Industry Trends Table 27. Artemisinin and Derivatives Industry Drivers Table 28. Artemisinin and Derivatives Industry Opportunities and Challenges Table 29. Artemisinin and Derivatives Industry Restraints Table 30. Global Artemisinin and Derivatives Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Artemisinin and Derivatives Revenue Market Share by Company (2021-2026) Table 32. Global Artemisinin and Derivatives Sales by Company (2021-2026) & (Tons) Table 33. Global Artemisinin and Derivatives Sales Share by Company (2021-2026) Table 34. Global Artemisinin and Derivatives Market Price by Company (2021-2026) & (US$/Ton) Table 35. Global Artemisinin and Derivatives Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Artemisinin and Derivatives Major Company Production Sites and Headquarters Table 37. Global Artemisinin and Derivatives Company, Product Type & Application Table 38. Global Artemisinin and Derivatives Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Artemisinin and Derivatives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Artemisinin and Derivatives Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Artemisinin and Derivatives Sales by Region (2021-2026) & (Tons) Table 43. Global Artemisinin and Derivatives Sales Market Share in Volume by Region (2021-2026) Table 44. Global Artemisinin and Derivatives Sales by Region (2021-2026) & (US$ Million) Table 45. Global Artemisinin and Derivatives Sales Market Share in Value by Region (2021-2026) Table 46. Global Artemisinin and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 47. Global Artemisinin and Derivatives Sales by Region (2027-2032) & (Tons) Table 48. Global Artemisinin and Derivatives Sales Market Share in Volume by Region (2027-2032) Table 49. Global Artemisinin and Derivatives Sales by Region (2027-2032) & (US$ Million) Table 50. Global Artemisinin and Derivatives Sales Market Share in Value by Region (2027-2032) Table 51. Global Artemisinin and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 52. Global Artemisinin and Derivatives Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons) Table 54. Global Artemisinin and Derivatives Sales Market Share in Volume by Application (2021-2026) Table 55. Global Artemisinin and Derivatives Sales by Application (2021-2026) & (US$ Million) Table 56. Global Artemisinin and Derivatives Sales Market Share in Value by Application (2021-2026) Table 57. Global Artemisinin and Derivatives Price by Application (2021-2026) & (US$/Ton) Table 58. Global Artemisinin and Derivatives Sales by Application (2027-2032) & (Tons) Table 59. Global Artemisinin and Derivatives Sales Market Share in Volume by Application (2027-2032) Table 60. Global Artemisinin and Derivatives Sales by Application (2027-2032) & (US$ Million) Table 61. Global Artemisinin and Derivatives Sales Market Share in Value by Application (2027-2032) Table 62. Global Artemisinin and Derivatives Price by Application (2027-2032) & (US$/Ton) Table 63. North America Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons) Table 64. North America Artemisinin and Derivatives Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons) Table 66. Europe Artemisinin and Derivatives Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons) Table 68. Asia-Pacific Artemisinin and Derivatives Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons) Table 70. Latin America Artemisinin and Derivatives Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons) Table 72. Middle East and Africa Artemisinin and Derivatives Sales by Application (2021-2026) & (US$ Million) Table 73. Ipca Laboratories Company Information Table 74. Ipca Laboratories Business Overview Table 75. Ipca Laboratories Artemisinin and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Ipca Laboratories Artemisinin and Derivatives Product Portfolio Table 77. Ipca Laboratories Recent Development Table 78. Guilin Nantang Pharmaceutical Company Information Table 79. Guilin Nantang Pharmaceutical Business Overview Table 80. Guilin Nantang Pharmaceutical Artemisinin and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Guilin Nantang Pharmaceutical Artemisinin and Derivatives Product Portfolio Table 82. Guilin Nantang Pharmaceutical Recent Development Table 83. KPC Pharmaceuticals Company Information Table 84. KPC Pharmaceuticals Business Overview Table 85. KPC Pharmaceuticals Artemisinin and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. KPC Pharmaceuticals Artemisinin and Derivatives Product Portfolio Table 87. KPC Pharmaceuticals Recent Development Table 88. Chongqing Kerui Nanhai Pharmaceutical Company Information Table 89. Chongqing Kerui Nanhai Pharmaceutical Business Overview Table 90. Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Product Portfolio Table 92. Chongqing Kerui Nanhai Pharmaceutical Recent Development Table 93. Sichuan Xieli Pharmaceutical Company Information Table 94. Sichuan Xieli Pharmaceutical Business Overview Table 95. Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Product Portfolio Table 97. Sichuan Xieli Pharmaceutical Recent Development Table 98. Cerata Pharmaceuticals Company Information Table 99. Cerata Pharmaceuticals Business Overview Table 100. Cerata Pharmaceuticals Artemisinin and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Cerata Pharmaceuticals Artemisinin and Derivatives Product Portfolio Table 102. Cerata Pharmaceuticals Recent Development Table 103. Aqre Group Company Information Table 104. Aqre Group Business Overview Table 105. Aqre Group Artemisinin and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Aqre Group Artemisinin and Derivatives Product Portfolio Table 107. Aqre Group Recent Development Table 108. North America Artemisinin and Derivatives Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 109. North America Artemisinin and Derivatives Sales by Country (2021-2026) & (Tons) Table 110. North America Artemisinin and Derivatives Sales Market Share by Country (2021-2026) Table 111. North America Artemisinin and Derivatives Sales Forecast by Country (2027-2032) & (Tons) Table 112. North America Artemisinin and Derivatives Sales Market Share Forecast by Country (2027-2032) Table 113. North America Artemisinin and Derivatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Artemisinin and Derivatives Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Artemisinin and Derivatives Market Share by Country (2021-2026) Table 116. North America Artemisinin and Derivatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Artemisinin and Derivatives Market Share Forecast by Country (2027-2032) Table 118. Europe Artemisinin and Derivatives Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 119. Europe Artemisinin and Derivatives Sales by Country (2021-2026) & (Tons) Table 120. Europe Artemisinin and Derivatives Sales Market Share by Country (2021-2026) Table 121. Europe Artemisinin and Derivatives Sales Forecast by Country (2027-2032) & (Tons) Table 122. Europe Artemisinin and Derivatives Sales Market Share Forecast by Country (2027-2032) Table 123. Europe Artemisinin and Derivatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Artemisinin and Derivatives Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Artemisinin and Derivatives Market Share by Country (2021-2026) Table 126. Europe Artemisinin and Derivatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Artemisinin and Derivatives Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Artemisinin and Derivatives Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Artemisinin and Derivatives Sales by Country (2021-2026) & (Tons) Table 130. Asia-Pacific Artemisinin and Derivatives Sales Market Share by Country (2021-2026) Table 131. Asia-Pacific Artemisinin and Derivatives Sales Forecast by Country (2027-2032) & (Tons) Table 132. Asia-Pacific Artemisinin and Derivatives Sales Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Artemisinin and Derivatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Artemisinin and Derivatives Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Artemisinin and Derivatives Market Share by Country (2021-2026) Table 136. Asia-Pacific Artemisinin and Derivatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Artemisinin and Derivatives Market Share Forecast by Country (2027-2032) Table 138. Latin America Artemisinin and Derivatives Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 139. Latin America Artemisinin and Derivatives Sales by Country (2021-2026) & (Tons) Table 140. Latin America Artemisinin and Derivatives Sales Market Share by Country (2021-2026) Table 141. Latin America Artemisinin and Derivatives Sales Forecast by Country (2027-2032) & (Tons) Table 142. Latin America Artemisinin and Derivatives Sales Market Share Forecast by Country (2027-2032) Table 143. Latin America Artemisinin and Derivatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Artemisinin and Derivatives Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Artemisinin and Derivatives Market Share by Country (2021-2026) Table 146. Latin America Artemisinin and Derivatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Artemisinin and Derivatives Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Artemisinin and Derivatives Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Artemisinin and Derivatives Sales by Country (2021-2026) & (Tons) Table 150. Middle East and Africa Artemisinin and Derivatives Sales Market Share by Country (2021-2026) Table 151. Middle East and Africa Artemisinin and Derivatives Sales Forecast by Country (2027-2032) & (Tons) Table 152. Middle East and Africa Artemisinin and Derivatives Sales Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Artemisinin and Derivatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Artemisinin and Derivatives Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East and Africa Artemisinin and Derivatives Market Share by Country (2021-2026) Table 156. Middle East and Africa Artemisinin and Derivatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Artemisinin and Derivatives Market Share Forecast by Country (2027-2032) Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Artemisinin and Derivatives Distributors List Table 161. Artemisinin and Derivatives Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Artemisinin and Derivatives Image Figure 2. Global Artemisinin and Derivatives Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artemisinin and Derivatives Market Size (2021-2032) & (US$ Million) Figure 4. Global Artemisinin and Derivatives Sales (2021-2032) & (Tons) Figure 5. Artemether Image Figure 6. Global Artemether Sales YoY Growth (2021-2032) & (Tons) Figure 7. Artesunate Image Figure 8. Global Artesunate Sales YoY Growth (2021-2032) & (Tons) Figure 9. Artemisinin Image Figure 10. Global Artemisinin Sales YoY Growth (2021-2032) & (Tons) Figure 11. Dihydroartemisinin Image Figure 12. Global Dihydroartemisinin Sales YoY Growth (2021-2032) & (Tons) Figure 13. Global Artemisinin and Derivatives Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Artemisinin and Derivatives Market Share by Type 2025 VS 2032 Figure 15. North America Artemisinin and Derivatives Sales Market Share in Volume by Type in 2025 Figure 16. North America Artemisinin and Derivatives Sales Market Share in Value by Type in 2025 Figure 17. Europe Artemisinin and Derivatives Sales Market Share in Volume by Type in 2025 Figure 18. Europe Artemisinin and Derivatives Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Artemisinin and Derivatives Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Artemisinin and Derivatives Sales Market Share in Value by Type in 2025 Figure 21. Latin America Artemisinin and Derivatives Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Artemisinin and Derivatives Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Artemisinin and Derivatives Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Artemisinin and Derivatives Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Artemisinin and Derivatives Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Antitumor and Anti-inflammatory Drugs Image Figure 28. Global Antitumor and Anti-inflammatory Drugs Sales YoY Growth (2021-2032) & (Tons) Figure 29. Antimalarial Drugs Image Figure 30. Global Antimalarial Drugs Sales YoY Growth (2021-2032) & (Tons) Figure 31. Global Artemisinin and Derivatives Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Artemisinin and Derivatives Market Share by Application 2025 VS 2032 Figure 33. North America Artemisinin and Derivatives Sales Market Share in Volume by Application in 2025 Figure 34. North America Artemisinin and Derivatives Sales Market Share in Value by Application in 2025 Figure 35. Europe Artemisinin and Derivatives Sales Market Share in Volume by Application in 2025 Figure 36. Europe Artemisinin and Derivatives Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Artemisinin and Derivatives Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Artemisinin and Derivatives Sales Market Share in Value by Application in 2025 Figure 39. Latin America Artemisinin and Derivatives Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Artemisinin and Derivatives Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Artemisinin and Derivatives Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Artemisinin and Derivatives Sales Market Share in Value by Application in 2025 Figure 43. North America Artemisinin and Derivatives Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. North America Artemisinin and Derivatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Artemisinin and Derivatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Artemisinin and Derivatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Artemisinin and Derivatives Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Europe Artemisinin and Derivatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Artemisinin and Derivatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Artemisinin and Derivatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Artemisinin and Derivatives Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Asia-Pacific Artemisinin and Derivatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Artemisinin and Derivatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Artemisinin and Derivatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Artemisinin and Derivatives Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Latin America Artemisinin and Derivatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Artemisinin and Derivatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Artemisinin and Derivatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Artemisinin and Derivatives Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Middle East and Africa Artemisinin and Derivatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Artemisinin and Derivatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Artemisinin and Derivatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Artemisinin and Derivatives Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Artemisinin and Derivatives Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Artemether
  • Artesunate
  • Artemisinin
  • Dihydroartemisinin
Applications
  • Antitumor and Anti-inflammatory Drugs
  • Antimalarial Drugs
Companies covered
  • Ipca Laboratories
  • Guilin Nantang Pharmaceutical
  • KPC Pharmaceuticals
  • Chongqing Kerui Nanhai Pharmaceutical
  • Sichuan Xieli Pharmaceutical
  • Cerata Pharmaceuticals
  • Aqre Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Artemisinin and Derivatives Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Artemisinin and Derivatives Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Artemisinin and Derivatives Market by Type
  6. 1.3.1 Artemether
  7. 1.3.2 Artesunate
  8. 1.3.3 Artemisinin
  9. 1.3.4 Dihydroartemisinin
  10. 1.4 Global Artemisinin and Derivatives Market Size by Type
  11. 1.4.1 Global Artemisinin and Derivatives Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Artemisinin and Derivatives Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Artemisinin and Derivatives Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Artemisinin and Derivatives Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Artemisinin and Derivatives Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Artemisinin and Derivatives Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Artemisinin and Derivatives Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Artemisinin and Derivatives Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Artemisinin and Derivatives Industry Trends
  2. 2.2 Artemisinin and Derivatives Industry Drivers
  3. 2.3 Artemisinin and Derivatives Industry Opportunities and Challenges
  4. 2.4 Artemisinin and Derivatives Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Artemisinin and Derivatives Revenue (2021-2026)
  2. 3.2 Global Top Players by Artemisinin and Derivatives Sales (2021-2026)
  3. 3.3 Global Top Players by Artemisinin and Derivatives Price (2021-2026)
  4. 3.4 Global Artemisinin and Derivatives Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Artemisinin and Derivatives Major Company Production Sites & Headquarters
  6. 3.6 Global Artemisinin and Derivatives Company, Product Type & Application
  7. 3.7 Global Artemisinin and Derivatives Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Artemisinin and Derivatives Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Artemisinin and Derivatives Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Artemisinin and Derivatives Tier 1, Tier 2, and Tier 3
4 Artemisinin and Derivatives Regional Status and Outlook
  1. 4.1 Global Artemisinin and Derivatives Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Artemisinin and Derivatives Historic Market Size by Region
  3. 4.2.1 Global Artemisinin and Derivatives Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Artemisinin and Derivatives Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Artemisinin and Derivatives Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Artemisinin and Derivatives Forecasted Market Size by Region
  7. 4.3.1 Global Artemisinin and Derivatives Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Artemisinin and Derivatives Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Artemisinin and Derivatives Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Artemisinin and Derivatives by Application
  1. 5.1 Artemisinin and Derivatives Market by Application
  2. 5.1.1 Antitumor and Anti-inflammatory Drugs
  3. 5.1.2 Antimalarial Drugs
  4. 5.2 Global Artemisinin and Derivatives Market Size by Application
  5. 5.2.1 Global Artemisinin and Derivatives Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Artemisinin and Derivatives Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Artemisinin and Derivatives Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Artemisinin and Derivatives Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Artemisinin and Derivatives Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Artemisinin and Derivatives Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Artemisinin and Derivatives Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Artemisinin and Derivatives Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Ipca Laboratories
  2. 6.1.1 Ipca Laboratories Company Information
  3. 6.1.2 Ipca Laboratories Business Overview
  4. 6.1.3 Ipca Laboratories Artemisinin and Derivatives Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Ipca Laboratories Artemisinin and Derivatives Product Portfolio
  6. 6.1.5 Ipca Laboratories Recent Developments
  7. 6.2 Guilin Nantang Pharmaceutical
  8. 6.2.1 Guilin Nantang Pharmaceutical Company Information
  9. 6.2.2 Guilin Nantang Pharmaceutical Business Overview
  10. 6.2.3 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Product Portfolio
  12. 6.2.5 Guilin Nantang Pharmaceutical Recent Developments
  13. 6.3 KPC Pharmaceuticals
  14. 6.3.1 KPC Pharmaceuticals Company Information
  15. 6.3.2 KPC Pharmaceuticals Business Overview
  16. 6.3.3 KPC Pharmaceuticals Artemisinin and Derivatives Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 KPC Pharmaceuticals Artemisinin and Derivatives Product Portfolio
  18. 6.3.5 KPC Pharmaceuticals Recent Developments
  19. 6.4 Chongqing Kerui Nanhai Pharmaceutical
  20. 6.4.1 Chongqing Kerui Nanhai Pharmaceutical Company Information
  21. 6.4.2 Chongqing Kerui Nanhai Pharmaceutical Business Overview
  22. 6.4.3 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Product Portfolio
  24. 6.4.5 Chongqing Kerui Nanhai Pharmaceutical Recent Developments
  25. 6.5 Sichuan Xieli Pharmaceutical
  26. 6.5.1 Sichuan Xieli Pharmaceutical Company Information
  27. 6.5.2 Sichuan Xieli Pharmaceutical Business Overview
  28. 6.5.3 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Product Portfolio
  30. 6.5.5 Sichuan Xieli Pharmaceutical Recent Developments
  31. 6.6 Cerata Pharmaceuticals
  32. 6.6.1 Cerata Pharmaceuticals Company Information
  33. 6.6.2 Cerata Pharmaceuticals Business Overview
  34. 6.6.3 Cerata Pharmaceuticals Artemisinin and Derivatives Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cerata Pharmaceuticals Artemisinin and Derivatives Product Portfolio
  36. 6.6.5 Cerata Pharmaceuticals Recent Developments
  37. 6.7 Aqre Group
  38. 6.7.1 Aqre Group Company Information
  39. 6.7.2 Aqre Group Business Overview
  40. 6.7.3 Aqre Group Artemisinin and Derivatives Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Aqre Group Artemisinin and Derivatives Product Portfolio
  42. 6.7.5 Aqre Group Recent Developments
7 North America by Country
  1. 7.1 North America Artemisinin and Derivatives Sales by Country
  2. 7.1.1 North America Artemisinin and Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Artemisinin and Derivatives Sales by Country (2021-2026)
  4. 7.1.3 North America Artemisinin and Derivatives Sales Forecast by Country (2027-2032)
  5. 7.2 North America Artemisinin and Derivatives Market Size by Country
  6. 7.2.1 North America Artemisinin and Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Artemisinin and Derivatives Market Size by Country (2021-2026)
  8. 7.2.3 North America Artemisinin and Derivatives Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Artemisinin and Derivatives Sales by Country
  2. 8.1.1 Europe Artemisinin and Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Artemisinin and Derivatives Sales by Country (2021-2026)
  4. 8.1.3 Europe Artemisinin and Derivatives Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Artemisinin and Derivatives Market Size by Country
  6. 8.2.1 Europe Artemisinin and Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Artemisinin and Derivatives Market Size by Country (2021-2026)
  8. 8.2.3 Europe Artemisinin and Derivatives Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Artemisinin and Derivatives Sales by Country
  2. 9.1.1 Asia-Pacific Artemisinin and Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Artemisinin and Derivatives Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Artemisinin and Derivatives Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Artemisinin and Derivatives Market Size by Country
  6. 9.2.1 Asia-Pacific Artemisinin and Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Artemisinin and Derivatives Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Artemisinin and Derivatives Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Artemisinin and Derivatives Sales by Country
  2. 10.1.1 South America Artemisinin and Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Artemisinin and Derivatives Sales by Country (2021-2026)
  4. 10.1.3 South America Artemisinin and Derivatives Sales Forecast by Country (2027-2032)
  5. 10.2 South America Artemisinin and Derivatives Market Size by Country
  6. 10.2.1 South America Artemisinin and Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Artemisinin and Derivatives Market Size by Country (2021-2026)
  8. 10.2.3 South America Artemisinin and Derivatives Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Artemisinin and Derivatives Sales by Country
  2. 11.1.1 Middle East and Africa Artemisinin and Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Artemisinin and Derivatives Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Artemisinin and Derivatives Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Artemisinin and Derivatives Market Size by Country
  6. 11.2.1 Middle East and Africa Artemisinin and Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Artemisinin and Derivatives Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Artemisinin and Derivatives Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Artemisinin and Derivatives Value Chain Analysis
  2. 12.1.1 Artemisinin and Derivatives Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Artemisinin and Derivatives Production Mode & Process
  7. 12.2 Artemisinin and Derivatives Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Artemisinin and Derivatives Distributors
  10. 12.2.3 Artemisinin and Derivatives Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst